The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Zai Lab Limited ADR shares valued at $188,039 were sold by Amado Rafael on Dec 31 ’25. At $17.43 per share, Amado Rafael sold 10,787 shares. The insider’s holdings dropped to 52,391 shares worth approximately $0.99 million following the completion of this transaction.
Also, Amado Rafael purchased 10,787 shares, netting a total of over 188,034 in proceeds.
Before that, Edmondson Frazor Titus III had sold 8,651 shares from its account. In a trade valued at $148,278, the Chief Legal Officer traded Zai Lab Limited ADR shares for $17.14 each. Upon closing the transaction, the insider’s holdings decreased to 8,651 shares, worth approximately $0.36 million.
Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early March. As of March 03, 2025, BofA Securities has decreased its “Buy” rating to a “Neutral” for ZLAB. Earlier on December 14, 2023, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for ZLAB stock.
Analyzing ZLAB Stock Performance
On last trading session, Zai Lab Limited ADR [NASDAQ: ZLAB] plunged -0.37% to $18.84. The stock’s lowest price that day was $18.46, but it reached a high of $19.005 in the same session. During the last five days, there has been a surge of approximately 0.64%. Over the course of the year, Zai Lab Limited ADR shares have dropped approximately -27.68%.
Is Zai Lab Limited ADR subject to short interest?
Stocks of Zai Lab Limited ADR saw a sharp steep in short interest on 2025-12-31 dropping by -0.79 million shares to 4.25 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 5.04 million shares. A decline of -18.57% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.11 of the overall float, the days-to-cover ratio (short ratio) decline to 5.11.
Which companies own the most shares of Zai Lab Limited ADR (ZLAB)?
In terms of Zai Lab Limited ADR share price expectations, FactSet research, analysts set an average price target of 35 in the next 12 months, up nearly 85.09% from the previous closing price of $18.91. Analysts anticipate Zai Lab Limited ADR stock to reach 35 by 2026, with the lowest price target being 35. In spite of this, 2 analysts ranked Zai Lab Limited ADR stock as Buy at the end of 2026. On August 10, 2023, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and initiated coverage with a $70.
